Alternative roles for Cdk5 in learning and synaptic plasticity

Biotechnology Journal

Volumn 2, Issue 8, 2007, Pages 941-948

  Hawasli, Ammar H ^a   Bibb, James A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cdk5; Cyclin dependent kinase 5; Learning; Plasticity

Indexed keywords

CALPAIN; CYCLIN DEPENDENT KINASE 5; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN P25; PROTEIN P35; CDK5 PROTEIN, HUMAN; NERVE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; CENTRAL NERVOUS SYSTEM; DRUG TARGETING; DYSKINESIA; ENZYME ACTIVITY; EVIDENCE BASED MEDICINE; GENE OVEREXPRESSION; GENETIC MANIPULATION; HUMAN; HUNTINGTON CHOREA; LEARNING; LONG TERM DEPRESSION; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NEUROMODULATION; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; BRAIN; ENZYMOLOGY; METABOLISM; NERVE CELL; PHOSPHORYLATION; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ANIMALS; BRAIN; CYCLIN-DEPENDENT KINASE 5; HUMANS; LEARNING; MODELS, NEUROLOGICAL; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; NEURONS; PHOSPHORYLATION; SYNAPTIC TRANSMISSION;

EID: 34548515717     PISSN: 18606768     EISSN: None     Source Type: Journal    
DOI: 10.1002/biot.200700093     Document Type: Review

References (61)

1. Lynch, M. A., Long-term potentiation and memory. Physiol. Rev. 2004, 84, 87-136.
2. Sweatt, J. D., Mechanisms of Memory, Elsevier, San Diego 2003.
3. Angejo, M., Plattner, F., Giese, K. P., Cyclin-dependent kinase 5 in synaptic plasticity, learning and memory. J. Neurochem. 2006, 99, 353-370.
4. Angelo, M., Plattner, F., Irvine, E. E., Giese, K. P., Improved reversal learning and altered fear conditioning in transgenic mice with regionally restricted p25 expression. Eur. J. Neurosci. 2003, 18, 423-431.
5. Fischer, A., Sananbenesi, F., Pang, P. T., Lu, B., Tsai, L. H., Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory. Neuron 2005, 48, 825-838.
6. Fischer, A., Sananbenesi, F., Schrick, C., Spiess, J., Radulovic, J., Cyclin-dependent kinase 5 is required for associative learning. J. Neurosci. 2002, 22, 3700-3707.
7. Fischer, A., Sananbenesi, F., Schrick, C., Spiess, J., Radulovic, J., Regulation of contextual fear conditioning by baseline and inducible septo-hippocampal cyclin-dependent kinase 5. Neuropharmacology 2003, 44, 1089-1099.
8. Ohshima, T., Ogura, H., Tomizawa, K., Hayashi, K. et al., Impairment of hippocampal long-term depression and defective spatial learning and memory in p35 mice. J. Neurochem. 2005, 94, 917-925.
9. Hawasli, A. H., Benavides, D. R., Nguyen, C., Kansy, J. W. et al., Cyclin-dependent kinase 5 governs learning end synaptic plasticity via regulation of NMDA receptor degradation. Nat. Neurosci. 2007, doi: 10.1038/nn1914
10. Cruz, J. C., Tsai, L. H., Cdk5 deregulation in the pathogenesis of Alzheimer's disease. Trends Mol. Med. 2004, 10, 452-458.
11. Ayala, R., Shu, T., Tsai, L. H., Trekking across the brain: The journey of neuronal migration. Cell 2007, 128, 29-43.
12. Gilmore, E. C., Ohshima, T., Goffinet, A. M., Kulkarni, A. B., Herrup, K., Cyclin-dependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex. J. Neurosci. 1998, 18, 6370-6377.
13. Ko, J., Humbert, S., Bronson, R. T., Takahashi, S. et al., p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J. Neurosci. 2001, 21, 6758-6771.
14. Ohshima, T., Ward, J. M., Huh, C. G., Longenecker, G. et al., Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc. Natl. Acad. Sci. USA 1996, 93, 11173-11178.
15. Chae, T., Kwon, Y. T., Bronson. R., Dikkes, P. et al., Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 1997, 18, 29-42.
16. Kwon, Y. T., Tsai, L. H., A novel disruption of cortical development in p35(-/-) mice distinct from reeler. J. Comp. Neurol. 1998, 395, 510-522.
17. Gupta, A., Tsai, L. H., Cyclin-dependent kinase 5 and neuronal migration in the neocortex. Neurosignals 2003, 12, 173-179.
18. Fletcher, A. I., Shuang, R., Giovannucci, D. R., Zhang, L. et al., Regulation of exocytosis by cyclin-dependent kinase 5 via phosphorylation of Munc18. J. Biol. Chem. 1999, 274, 4027-4035.
19. Shuang, R., Zhang, L., Fletcher, A., Groblewski, G. E. et al., Regulation of Munc-18/syntaxin 1A interaction by cyclin-dependent kinase 5 in nerve endings. J. Biol. Chem. 1998, 273, 4957-4966.
20. Tomizawa, K., Ohta, J., Matsushita, M., Moriwaki, A. et al., Cdk5/ p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. J. Neurosci. 2002, 22, 2590-2597.
21. Cheng, K., Ip, N. Y., Cdk5: A new player at synapses. Neurosignals 2003, 12, 180-190.
22. Evans, G. J., Cousin, M. A., Activity-dependent control of slow synaptic vesicle endocytosis by cyclin-dependant kinase 5. J. Neurosci. 2007, 27, 401-411.
23. Graham, M. E., Anggono, V., Bache, N., Larsen, M. R. et al., The in vivo phosphorylation sites of rat brain dynamin I. J. Biol. Chem. 2007, 282, 14695-14707.
24. Benavides, D. R., Bibb, J. A., Role of Cdk5 in drug abuse and plasticity. Ann. N. Y. Acad. Sci. 2004, 1025, 335-344.
25. Bibb, J. A., Role of Cdk5 in neuronal signaling, plasticity, and drug abuse. Neurosignals 2003, 12, 191-199.
26. Li, B. S., Sun, M. K., Zhang, L., Takahashi, S. et al., Regulation of NMDA receptors by cyclin-dapendent kinase-5. Proc. Natl. Acad. Sci. USA 2001, 98, 12742-12747.
27. Wang, Q., Walsh, D. M., Rowan, M. J., Selkoe, D. J., Anwyl, R., Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. J. Neurosci. 2004, 24, 3370-3378.
28. Cho, S., Meriney, S. D., The effects of presynaptic calcium channel modulation by roscovitine on transmitter release at the adult frog neuromuscular junction. Eur. J. Neurosci. 2006, 23, 3200-3208.
29. Yan, Z., Chi, P., Bibb, J. A., Ryan, T. A., Greengard, P., Roscovitine: a novel regulator of P/Q-type calcium channels and transmitter release in central neurons. J. Physiol. 2002, 540, 761-770.
30. Buraei, Z., Schofield, G., Elmslie, K. S., Roscovitine differentially affects CaV2 and Kv channels by binding to the open state. Neuropharmacology 2007, 52, 883-894.
31. Wei, F. Y., Tomizawa, K., Ohshima, T., Asada, A. et al., Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability. J. Neurochem. 2005, 93, 502-512.
32. Patel, L. S., Wenzel, H. J., Schwartzkroin, P. A., Physiological and morphological characterization of dentate granule cells in the p35 knock-out mouse hippocampus: evidence for an epileptic circuit. J. Neurosci. 2004, 24, 9005-9014.
33. Wenzel, H. J., Robbins, C. A., Tsai. L. H., Schwartzkroin, P. A., Abnormal morphological and functional organization of the hippocampus in a p36 mutant model of cortical dysplasia associated with spontaneous seizures. J. Neurosci. 2001, 21, 983-998.
34. Patrick, G. N., Zukerberg, L., Nikolic, M., de la Monte, S. et al., Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 1999, 402, 615-622.
35. Lau, L. F., Ahlijanian, M. K., Role of cdk5 in the pathogenesis of Alzheimer's disease. Neurosignals 2003, 12, 209-214.
36. Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M., Tsai, L. H., Recovery of learning and memory is associated with chromatin remodelling. Nature 2007, 447, 178-182.
37. Ris, L., Angelo, M., Plattner, F., Capron, B. et al., Sexual dimorphisms in the effect of low-level p25 expression on synaptic plasticity and memory. Eur. J. Neurosci. 2005, 21, 3023-3033.
38. Mizuno, K., Plattner, F., Peter Giese, K., Expression of p25 impairs contextual learning but not latent inhibition in mice. Neuroreport 2006, 17, 1903-1905.
39. Lee, M. S., Kwon, Y. T., Li, M., Peng, J. et al., Neuxotoxicity induces cleavage of p35 to p25 by calpain. Nature 2000, 405, 360-364.
40. Morabito, M. A., Sheng, M., Tsai, L. H., Cyclin-dependent kinase 5 phosphorylates the N-terminal domain of the postsynaptic density protein PSD-95 in neurons. J. Neurosci. 2004, 24, 865-876.
41. Masliah, E., Crews, L., Hansen, L., Synaptic remodeling during aging and in Alzheimer's disease. J. Alzheimer's Dis. 2006, 9, 91-99.
42. Weber, P., Metzger, D., Chambon, P., Temporally controlled targeted somatic mutagenesis in the mouse brain. Eur. J. Neurosci. 2001, 14, 1777-1783.
43. Bernasconi-Guastalla, S., Wolfer, D. P., Lipp, H. P., Hippocampal mossy fibers and swimming navigation in mice: correlations with size and left-right asymmetries. Hippocampus 1994, 4, 53-63.
44. Nakazawa, K., Sun, L. D., Quirk, M. C., Rondi-Reig, L. et al., Hippocampal CA3 NMDA receptors are crucial for memory acquisition of one-time experience. Neuron 2003, 38, 305-315.
45. Liu, L., Wong, T. P., Pozza, M. F., Lingenhoehl, K. et al., Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 2004, 304, 1021-1024.
46. Tang, Y. P., Shimizu, E., Dube, G. R., Rampon, C. et al., Genetic enhancement of learning and memory in mice. Nature 1999, 401, 63-69.
47. Guttmann, R. P., Baker, D. L., Seifert, K. M., Cohen, A. S. et al., Specific proteolysis of the NR2 subunit at multiple sites by calpain. J. Neurochem. 2001, 78, 1083-1093.
48. Guttmann, R. P., Sokol, S., Baker, D. L., Simpkins, K. L. et al., Proteolysis of the N-methyl-D-aspartate receptor by calpain in situ. J. Pharmacol. Exp. Ther. 2002, 302, 1023-1030.
49. Simpkins, K. L., Guttmann, R. P., Dong, Y., Chen, Z. et al.. Selective activation induced cleavage of the NR2B subunit by calpain. J. Neurosci. 2003, 23, 11322-11331.
50. Husi, H., Ward, M. A., Choudhary, J. S., Blackstock, W. P., Grant, S. G., Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat. Neurosci. 2000, 3, 661-669.
51. Liu, M. C., Akle, V., Zheng, W., Dave, J. R. et al., Comparing calpain- and caspase-3-mediated degradation patterns in traumatic brain injury by differential proteome analysis. Biochem. J. 2006, 394, 715-725.
52. Kusakawa, G., Saito, T., Onuki, R., Ishiguro, K. et al., Calpain-dependant proteolyttc cleavage of the p35 cyclin-dependent kinase 5 activator to p25. J. Biol. Chem. 2000, 275, 17166-17172.
53. Suzuki, K., Sorimachi, H., A novel aspect of calpain activation. FEBS Lett. 1998, 433, 1-4.
54. Picconi, B., Centonze, D., Hakansson, K., Bernardi, G. et al., Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat. Neurosci. 2003, 6, 501-506.
55. Bibb, J. A., Snyder, G. L., Nishi, A., Yan, Z. et al., Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 1999, 402, 669-671.
56. Di Filippo, M., Tozzi, A., Picconi, B., Ghiglieri, V., Calabresi, P., Plastic abnormalities in experimental Huntington's disease. Curr. Opin. Pharmacol. 2007, 7, 106-111.
57. Calabresi, P., Centonze, D., Pisani, A., Cupini, L., Bernardi, G., Synaptic plasticity in the ischaemic brain. Lancet Neurol. 2003, 2, 622-629.
58. Wang, J., Liu, S., Fu, Y., Wang, J. H., Lu, Y., Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors. Nat. Neurosci. 2003, 6, 1039-1047.
59. Bayer, K. U., LeBel, E., McDonald, G. L., O'Leary, H. et al., Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B. J. Neurosci. 2006, 26, 1164-1174.
60. Gardoni, F., Bellone, C., Cattabeni, F., Di Luca, M., Protein kinase C activation modulates alpha-calmodulin kinase II binding to NR2A subunit of N-methyl-D-aspartate receptor complex. J. Biol. Chem. 2001, 276, 7609-7613.
61. 2+/ calmodulin-dependant kinase II. Mol. Cell 2003, 11, 1241-1251.